Cetera Investment Advisers
ARDT

Cetera Investment Advisers’s Ardent Health ARDT Stock Holding History

Cetera Investment Advisers’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,287
Closed -$163K – 4898
2025
Q3 		$163K Buy
+12,287
New +$154K ﹤0.01% 4206

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $80M AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Cetera Investment Advisers's ARDT Position: Q4 2025 in Review

Cetera Investment Advisers sold out of Ardent Health (ARDT) in Q4 2025, closing a stake of 12,287 shares — an estimated $163K sold.

Cetera Investment Advisers first reported a position in ARDT in Q3 2025 and held it in 1 quarter. The position peaked at $163K in Q3 2025. 127 funds tracked by Wall St. Rank hold ARDT as of Q4 2025.

  • Cetera Investment Advisers reported no remaining Ardent Health position as of Q4 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 12,287 Ardent Health shares in Q4 2025, an estimated $163K.
  • Cetera Investment Advisers first reported a position in Ardent Health in Q3 2025 and held it in 1 quarter.
  • Cetera Investment Advisers's Ardent Health position peaked at $163K in Q3 2025.
  • 127 funds tracked by Wall St. Rank held Ardent Health as of Q4 2025.

Based on Cetera Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.